6:18 PM
 | 
Jan 29, 2014
 |  BC Extra  |  Company News

Teva prices thrice-weekly Copaxone

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) set the wholesale acquisition cost (WAC) of a four-week supply of its thrice-weekly 40 mg dose of multiple sclerosis (MS) drug Copaxone glatiramer acetate at $4,641.24, which translates to an annual WAC of about...

Read the full 185 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >